MedPath

Study of Darvyadi Leha in anemia of childre

Phase 2
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Registration Number
CTRI/2022/07/044074
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Hemoglobin 7.5-11gm/dl

Exclusion Criteria

1.Other causes of anemia, apart from iron deficiency, apparent by history and physical examination

2.Known cases of hemoglobinopathies especially Thalassemia.

3.Iron deficiency likely or definitely due to blood loss from the intestine or other sites

4.Hemoglobin below 7.5gm/dl.

5.History or evidence of intestinal malabsorption or any GIT pathology which may hamper the oral iron therapy administration

6.Hypersensitivity to iron therapy and other components of the study drugs.

7.Known cases of chronic debilitating illness like TB, Juvenile Diabetes etc.

8.Patients with concurrent Hepatic disease, Renal disease, Bronchial Asthma, Cardiovascular disease.

9.Any other clinical condition which may impact the study outcomes as per the study investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean change in HemoglobinTimepoint: At baseline, 30 days, 60 days, 90 days, 120 days
Secondary Outcome Measures
NameTimeMethod
1. Proportion of participants who attained Hb within the normal reference range (defined as Hb â?¥11 g/dl) <br/ ><br>2. Change in ferritin levels <br/ ><br>3.RBC count, MCV and MCH <br/ ><br>4.Absolute Reticulocyte count <br/ ><br>Timepoint: At baseline and at 90 days
© Copyright 2025. All Rights Reserved by MedPath